Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CareFusion Will Expand IV Infusion Portfolio With $225 Mil. Medegen Buy

This article was originally published in The Gray Sheet

Executive Summary

CareFusion says its planned $225 million acquisition of needleless intravenous infusion device maker Medegen will improve its ability to compete on claims of reducing hospital-acquired infections

You may also be interested in...



CareFusion: Increased Infusion Sales Offset By Light Flu Season

CareFusion had mixed results last quarter, combining increased infusion pump sales offset by reduced respiratory revenues, due, in part, to a lighter flu season, the firm said Nov. 2.

CareFusion: Increased Infusion Sales Offset By Light Flu Season

CareFusion had mixed results last quarter, combining increased infusion pump sales offset by reduced respiratory revenues, due, in part, to a lighter flu season, the firm said Nov. 2.

CareFusion Aims To Accelerate Infusion Sales Growth Post Baxter Recall

CareFusion expects to grow infusion system sales at a brisk rate in fiscal 2011, in part by capitalizing on Baxter's ongoing infusion pump recall, the firm said during its Aug. 10 earnings call

Related Content

Topics

UsernamePublicRestriction

Register

MT028714

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel